Calithera Biosciences (CALA) Will Present Preclinical Data on CB-839 at 2016 ASH Meeting
Tweet Send to a Friend
Calithera Biosciences, Inc. (Nasdaq: CALA) announced that preclinical data for its lead drug candidate CB-839, the company's novel, orally bioavailable ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
